½ÃÀ庸°í¼­
»óǰÄÚµå
1652108

õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå, ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå ¿¹Ãø(2025-2034³â)

Sacral Nerve Stimulation Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 125 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 5Á¶ 3,348¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀåÀº ±â±âÀÇ È¿°ú¿Í °æÁ¦¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ »ó´çÇÑ ¼ºÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. õ°ñ ½Å°æ ÀÚ±Ø ÀåÄ¡ÀÇ Á¤±³ÇÔ°ú ºñ¿ë È¿À²¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó ÀÇ·áÁø°ú ȯÀÚµé »çÀÌ¿¡¼­ äÅ÷üÀÌ ³ô¾ÆÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 8¿ù¿¡ Ãâ½ÃµÈ ¸ÞµåÆ®·Î´ÐÀÇ ÀÎÅͽºÆÀ ¸¶ÀÌÅ©·Î ÃæÀü½Ä õ°ñ ½Å°æÁ¶Àý ½Ã½ºÅÛÀº ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» º¸¿©ÁÖ¸ç ´õ ³ªÀº ¼º´É°ú ȯÀÚ ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº Ä¡·á ¿É¼ÇÀ» È®´ëÇϰí ȯÀÚÀÇ ÀڽۨÀ» ³ô¿© ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀåÀº ÃÖ¼Ò Ä§½À ½Ã¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³ÀÇÇеµ¼­°ü¿¡ µû¸£¸é ÇöÀç ÃÖ¼Ò Ä§½À ½Ã¼úÀÇ Ã¤Å÷üÀº 80-90%¿¡ ´ÞÇÕ´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁøÀº Á¡Á¡ ´õ ºü¸¥ ȸº¹°ú ÀûÀº ÇÕº´ÁõÀ» Á¦°øÇÏ´Â ´ú ħ½ÀÀûÀÎ ¿É¼ÇÀ» ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼±È£µµÀÇ º¯È­´Â ¿ä½Ç±Ý°ú º¯½Ç±Ý¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ Ä¡·á¹ýÀ¸·Î õ°ñ ½Å°æ Àڱؿ¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ½ÃÀå È®´ë¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

GDP ´ëºñ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϸ鼭 õ°ñ ½Å°æ Àڱر⿡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÏ¿© ¿ä½Ç±Ý ¹× º¯½Ç±Ý°ú °°Àº Áúȯ¿¡ ´ëÇÑ È¯ÀÚ °ü¸® ¹× Ä¡·á ¿É¼ÇÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.

õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç° À¯Çüº°·Î´Â ÀåÄ¡ ºÎ¹®Àº ¼¼°èÀÇ ½ÃÀå¿¡¼­ »ó´çÇÑ CAGR·Î »ó´çÇÑ ¼ºÀåÀ» °æÇèÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¼ÒÇüÈ­ ¹× ±â´É Çâ»óÀ¸·Î ÀÎÇÑ »õ·Î¿î ÀåÄ¡ äÅÃÀÇ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î º´¿ø ºÎ¹®Àº º´¿ø ÀÔ¿ø ¹× Àå±â ÀÔ¿øÀÇ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¼¼°èÀÇ ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2024³â ºÏ¹Ì´Â ÀÌ Áö¿ªÀÇ º´¿ø ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°è õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀåÀ» Áö¹èÇß½À´Ï´Ù.

µ¶ÀÏÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀåÀº ÀÇ·á¿¡ ´ëÇÑ Á¤ºÎ ÁöÃâ Áõ°¡·Î ÀÎÇØ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ ÁÖ¿ä ½ÃÀå ±â¾÷À¸·Î´Â Saluda Medical Pty Ltd., Medtronic plc, Beijing PINS Medical Co., Ltd., Axonics, Inc., Boston Scientific Corporation, Nervo Corp., Stimwave Technologies Inc. µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ÃÖ¼Ò Ä§½À ½Ã¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎ
      • ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϸ鼭 ¼ö¿ä°¡ Áõ°¡
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • Á¦Á¶¸¦ À§ÇÑ ³ôÀº Ãʱâ ÅõÀÚ¾×
  • PESTEL ºÐ¼®
  • õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÀåÄ¡
  • ºÎ¼Óǰ

Á¦6Àå ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¿ä½Ç±Ý ¹× º¯½Ç±Ý
  • ¸¸¼º Ç×¹® ¿­»ó
  • Àý¹Ú¼º ¿ä½Ç±Ý
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Ãµ°ñ ½Å°æ ÀÚ±Ø ½ÃÀå : Áö¿ª

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • õ°ñ ½Å°æ ÀÚ±Ø ½ÃÀåÀÇ Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
    • ºÏ¹Ì : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Á¦Ç° À¯Çüº°(2020-2034³â)
    • À¯·´ : ¿ëµµº°(2020-2034³â)
    • À¯·´ : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ, Çù¾÷, ÇÕÀÇ, °ø°³

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Saluda Medical Pty Ltd
  • Medtronic plc
  • Beijing PINS Medical Co., Ltd.
  • Axonics, Inc.
  • Boston Scientific Corporation
  • Nervo Corp.
  • Stimwave Technologies Inc.
  • St. Jude Medical
  • Congentix Medical
HBR 25.03.10

The global sacral nerve stimulation market size is expected to reach USD 5,334.82 million by 2034, according to a new study by Polaris Market Research. The report "Sacral Nerve Stimulation Market Size, Share, Trends, Industry Analysis Report: By Product Type (Devices and Accessories), Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The sacral nerve stimulation market is experiencing significant growth due to advancements in technology that enhance device effectiveness and affordability. Increased sophistication and cost-effectiveness of sacral nerve stimulation devices are likely to drive higher adoption rates among healthcare providers and patients. For instance, Medtronic's launch of the InterStim Micro Rechargeable Sacral Neuromodulation System in August 2020 shows innovation in this field, offering better performance and patient convenience. These developments expand treatment options and boost patient confidence, thereby contributing to the market growth.

The sacral nerve stimulation market is expanding due to the rising adoption of minimally invasive procedures. For instance, according to the National Library of Medicine, minimally invasive procedures currently have an adoption rate of 80% to 90%. Patients and healthcare providers increasingly prefer less invasive options that offer quicker recovery and fewer complications. This shift in preference has increased the demand for sacral nerve stimulation as an appealing treatment for urinary and fecal incontinence, positively impacting the market expansion.

Rising healthcare expenditure, as a percentage of GDP, is driving the demand for sacral nerve stimulators. This has led to increased investment in advanced medical technologies, enhancing patient care and treatment options for conditions like urinary and fecal incontinence.

Sacral Nerve Stimulation Market Report Highlights

Based on product type, the device segment is anticipated to experience substantial growth with a significant CAGR in the global market. This growth is attributed to an increase in the adoption of new devices due to miniaturization and enhanced functionality.

Based on end user, the hospitals segment is expected to dominate the global market in the forecasted years, driven by the increase in hospital admissions and extended hospital stays.

In 2024, North America dominated the global sacral nerve stimulation market due to the increasing number of hospitals in the region.

The sacral nerve stimulation market in Germany is projected for substantial growth due to increasing government expenditure on healthcare.

A few of the global key market players are Saluda Medical Pty Ltd.; Medtronic plc; Beijing PINS Medical Co., Ltd.; Axonics, Inc.; Boston Scientific Corporation; Nervo Corp.; Stimwave Technologies Inc.; St. Jude Medical; and Congentix Medical.

Polaris Market Research has segmented the sacral nerve stimulation market research report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue - USD Million, 2020-2034)

  • Devices
  • Accessories

By Application Outlook (Revenue - USD Million, 2020-2034)

  • Urinary and Fecal Incontinence
  • Chronic Anal Fissure
  • Urge Incontinence
  • Others

By End User Outlook (Revenue - USD Million, 2020-2034)

  • Hospitals
  • Speciality Clinics
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Sacral Nerve Stimulation Market Insights

  • 4.1. Sacral Nerve Stimulation Market - Market Snapshot
  • 4.2. Sacral Nerve Stimulation Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Adoption of Minimally Invasive Procedures Are Driving Market Growth
      • 4.2.1.2. Rising Healthcare Expenditure is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment for Manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Sacral Nerve Stimulation Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Sacral Nerve Stimulation Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
  • 5.3. Devices
    • 5.3.1. Global Sacral Nerve Stimulation Market, by devices, by Region, 2020-2034 (USD million)
  • 5.4. Accessories
    • 5.4.1. Global Sacral Nerve Stimulation Market, by Accessories, by Region, 2020-2034 (USD million)

6. Global Sacral Nerve Stimulation Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
  • 6.3. Urinary and Fecal Incontinence
    • 6.3.1. Global Sacral Nerve Stimulation Market, by Urinary and Fecal Incontinence, by Region, 2020-2034 (USD million)
  • 6.4. Chronic Anal Fissure
    • 6.4.1. Global Sacral Nerve Stimulation Market, by Chronic Anal Fissure, by Region, 2020-2034 (USD million)
  • 6.5. Urge Incontinence
    • 6.5.1. Global Sacral Nerve Stimulation Market, by Urge Incontinence, by Region, 2020-2034 (USD million)
  • 6.6. Others
    • 6.6.1. Global Sacral Nerve Stimulation Market, by Others, by Region, 2020-2034 (USD million)

7. Global Sacral Nerve Stimulation Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
  • 7.3. Hospitals
    • 7.3.1. Global Sacral Nerve Stimulation Market, by Hospitals, by Region, 2020-2034 (USD million)
      • 7.3.1.1.
  • 7.4. Speciality Clinics
    • 7.4.1. Global Sacral Nerve Stimulation Market, by Specialty Clinics, by Region, 2020-2034 (USD million)
  • 7.5. Other
    • 7.5.1. Global Sacral Nerve Stimulation Market, by Others, by Region, 2020-2034 (USD million)

8. Global Sacral Nerve Stimulation Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Sacral Nerve Stimulation Market Assessment, By Geography, 2020-2034 (USD million)
  • 8.3. Sacral Nerve Stimulation Market - North America
    • 8.3.1. North America: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
    • 8.3.2. North America: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
    • 8.3.3. North America: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.3.4. Sacral Nerve Stimulation Market - U.S.
      • 8.3.4.1. U.S.: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.3.4.2. U.S.: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.3.4.3. U.S.: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.3.5. Sacral Nerve Stimulation Market - Canada
      • 8.3.5.1. Canada: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.3.5.2. Canada: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.3.5.3. Canada: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
  • 8.4. Sacral Nerve Stimulation Market - Europe
    • 8.4.1. Europe: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
    • 8.4.2. Europe: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
    • 8.4.3. Europe: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.4. Sacral Nerve Stimulation Market - UK
      • 8.4.4.1. UK: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.4.2. UK: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.4.3. UK: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.5. Sacral Nerve Stimulation Market - France
      • 8.4.5.1. France: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.5.2. France: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.5.3. France: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.6. Sacral Nerve Stimulation Market - Germany
      • 8.4.6.1. Germany: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.6.2. Germany: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.6.3. Germany: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.7. Sacral Nerve Stimulation Market - Italy
      • 8.4.7.1. Italy: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.7.2. Italy: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.7.3. Italy: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.8. Sacral Nerve Stimulation Market - Spain
      • 8.4.8.1. Spain: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.8.2. Spain: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.8.3. Spain: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.9. Sacral Nerve Stimulation Market - Netherlands
      • 8.4.9.1. Netherlands: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.9.2. Netherlands: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.9.3. Netherlands: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.10. Sacral Nerve Stimulation Market - Russia
      • 8.4.10.1. Russia: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.10.2. Russia: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.10.3. Russia: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.4.11. Sacral Nerve Stimulation Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.4.11.2. Rest of Europe: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.4.11.3. Rest of Europe: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
  • 8.5. Sacral Nerve Stimulation Market - Asia Pacific
    • 8.5.1. Asia Pacific: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
    • 8.5.2. Asia Pacific: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
    • 8.5.3. Asia Pacific: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.4. Sacral Nerve Stimulation Market - China
      • 8.5.4.1. China: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.4.2. China: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.4.3. China: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.5. Sacral Nerve Stimulation Market - India
      • 8.5.5.1. India: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.5.2. India: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.5.3. India: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.6. Sacral Nerve Stimulation Market - Malaysia
      • 8.5.6.1. Malaysia: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.6.2. Malaysia: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.6.3. Malaysia: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.7. Sacral Nerve Stimulation Market - Japan
      • 8.5.7.1. Japan: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.7.2. Japan: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.7.3. Japan: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.8. Sacral Nerve Stimulation Market - Indonesia
      • 8.5.8.1. Indonesia: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.8.2. Indonesia: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.8.3. Indonesia: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.9. Sacral Nerve Stimulation Market - South Korea
      • 8.5.9.1. South Korea: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.9.2. South Korea: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.9.3. South Korea: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.10. Sacral Nerve Stimulation Market - Australia
      • 8.5.10.1. Australia: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.10.2. Australia: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.10.3. Australia: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.5.11. Sacral Nerve Stimulation Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
  • 8.6. Sacral Nerve Stimulation Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
    • 8.6.2. Middle East & Africa: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
    • 8.6.3. Middle East & Africa: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.6.4. Sacral Nerve Stimulation Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.6.4.2. Saudi Arabia: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.6.4.3. Saudi Arabia: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.6.5. Sacral Nerve Stimulation Market - UAE
      • 8.6.5.1. UAE: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.6.5.2. UAE: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.6.5.3. UAE: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.6.6. Sacral Nerve Stimulation Market - Israel
      • 8.6.6.1. Israel: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.6.6.2. Israel: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.6.6.3. Israel: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.6.7. Sacral Nerve Stimulation Market - South Africa
      • 8.6.7.1. South Africa: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.6.7.2. South Africa: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.6.7.3. South Africa: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.6.8. Sacral Nerve Stimulation Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
  • 8.7. Sacral Nerve Stimulation Market - Latin America
    • 8.7.1. Latin America: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
    • 8.7.2. Latin America: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
    • 8.7.3. Latin America: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.7.4. Sacral Nerve Stimulation Market - Mexico
      • 8.7.4.1. Mexico: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.7.4.2. Mexico: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.7.4.3. Mexico: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.7.5. Sacral Nerve Stimulation Market - Brazil
      • 8.7.5.1. Brazil: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.7.5.2. Brazil: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.7.5.3. Brazil: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.7.6. Sacral Nerve Stimulation Market - Argentina
      • 8.7.6.1. Argentina: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.7.6.2. Argentina: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.7.6.3. Argentina: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)
    • 8.7.7. Sacral Nerve Stimulation Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Sacral Nerve Stimulation Market, by Product Type, 2020-2034 (USD million)
      • 8.7.7.2. Rest of Latin America: Sacral Nerve Stimulation Market, by Application, 2020-2034 (USD million)
      • 8.7.7.3. Rest of Latin America: Sacral Nerve Stimulation Market, by End User, 2020-2034 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Saluda Medical Pty Ltd
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Medtronic plc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Beijing PINS Medical Co., Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Axonics, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Boston Scientific Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Nervo Corp.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Stimwave Technologies Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. St. Jude Medical
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Congentix Medical
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦